M. Kuipers

发表

Open-label study of the safety and pharmacokinetics of solifenacin in subjects with hepatic impairment.

R. Smulders, W. Krauwinkel, T. Hoon, 2006, Journal of pharmacological sciences.

Molecular Mechanisms of the Adsorption of a Model Protein (Human Serum Albumin) on Poly(Methylidene Malonate 2.1.2) Nanoparticles

D. Meijer, J. Hoebeke, P. J. Swart, 2004, Pharmaceutical Research.

Conditions influencing the in vitro antifungal activity of lactoferrin combined with antimycotics against clinical isolates of Candida

D. Meijer, J. J. van den Berg, M. Kuipers, 2002, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Prediction of the pharmacokinetics of succinylated human serum albumin in man from in vivo disposition data in animals and in vitro liver slice incubations.

P. Olinga, J. Proost, G. Groothuis, 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

The Pharmacokinetic Profile of Tamsulosin Oral Controlled Absorption System (OCAS

W. Krauwinkel, M. Michel, C. Korstanje, 2005 .

Design and Fungicidal Activity of Mucoadhesive Lactoferrin Tablets for the Treatment of Oropharyngeal Candidosis

D. Meijer, H. Bakker, P. J. Swart, 2002, Drug delivery.

Pharmacokinetic interaction of solifenacin with an oral contraceptive containing ethinyl estradiol and levonorgestrel in healthy women: a double-blind, placebo-controlled study.

R. Smulders, W. Krauwinkel, M. E. Taekema-Roelvink, 2005, Clinical therapeutics.

A first-in-man phase 1 study of the DNA-dependent protein kinase inhibitor peposertib (formerly M3814) in patients with advanced solid tumours

J. Schellens, H. Verheul, A. Awada, 2020, British Journal of Cancer.

Solifenacin Demonstrates High Absolute Bioavailability in Healthy Men

W. Krauwinkel, H. Mulder, M. Kuipers, 2004, Drugs in R&D.

Charge modification of plasma and milk proteins results in antiviral active compounds

E. De Clercq, R. Pauwels, M. Harmsen, 1999, Journal of peptide science : an official publication of the European Peptide Society.

Safety, clinical activity and pharmacological biomarker evaluation of the DNA-dependent protein kinase (DNA-PK) inhibitor M3814: Results from two phase I trials.

V. Budach, J. Debus, H. Verheul, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Calcipotriol cream in the morning and ointment in the evening: a novel regimen to improve compliance.

P. C. van de Kerkhof, P. Kerkhof, M. Kuipers, 2001, The Journal of dermatological treatment.

Multiple doses of the antimuscarinic agent solifenacin do not affect the pharmacodynamics or pharmacokinetics of warfarin or the steady-state pharmacokinetics of digoxin in healthy subjects.

R. Smulders, W. Krauwinkel, M. Kuipers, 2006, British journal of clinical pharmacology.